Home | dermcity | Page 2 of 141

Models predict low mortality in certain patients with stage 1 melanoma

According to a new study, models based on cancer registry data can help identify subsets of stage 1 melanoma patients with very low...

Reactivating fetal healing protein NPGPx could improve chronic diabetic wounds

Recent research has shown promising early results in re-activating a protein associated with rapid wound healing. The protein quickly...

VIDEO: Prolonged corticosteroid exposure linked to adverse effects in AD patients, study shows

Adult and pediatric AD patients have experienced more adverse effects after prolonged use of corticosteroids.

Spinach derivative shows promise in AD

An early investigational report indicates that a compound derived from baby spinach leaves may be developed into an effective topical...

Relatlimab/nivolumab combo improves melanoma outcomes, may avoid surgery

Findings from a study of patients with stage III melanoma treated with a combination of the immune checkpoint inhibitors relatlimab and...

VIDEO: New study shows tralokinumab use for AD not related to Covid-19 severity

Tralokinumab treatment in patients with AD does not increase Covid-19 severity or interfere with Covid-19 vaccinations.

New molecule may block melanoma growth

Researchers at Emory University in Atlanta have synthesized a novel molecule called indolium 1 that blocks the growth of melanoma cells,...

Impact of extreme weather on skin health evaluated

Findings from a literature review examining the impact of extreme weather events on skin health suggest that climate change will worsen...

2

it's where dermatology lives